{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:04:46Z","timestamp":1793862286017,"version":"4.6.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To determine whether intrawound vancomycin changes the bacteriology of surgical site infection pathogens and investigate the emergence of antibiotic-resistant pathogens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Secondary analysis of phase III, prospective, randomized clinical trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Thirty-six US trauma centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Selection Criteria:<\/jats:title>\n            <jats:p>Patients who became infected after fixation of tibial plateau or pilon fracture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome Measures and Comparisons:<\/jats:title>\n            <jats:p>Pathogen types and bacterial susceptibilities as determined from routine clinical culture in the operating room.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Seventy-four patients were studied who were 67.5% male with a mean age of 48.6 years. A lower proportion of gram-positive cocci was observed in the vancomycin powder compared with the standard-of-care group (3.7% vs. 8.0%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). Methicillin-resistant <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> infection incidence was comparable in both the vancomycin powder and the standard-of-care groups, but rates of methicillin-susceptible <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> infections were lower in the treatment group (1.4% vs. 4.8%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). The incidence of coagulase-negative <jats:italic toggle=\"yes\">Staphylococci<\/jats:italic> and gram-negative rod infections were similar in both groups. There was no significant difference in susceptibilities between groups in rates of vancomycin-resistant enterococcus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Topical vancomycin powder decreases the likelihood of gram-positive infections consistent with the biologic activity of vancomycin. Fewer methicillin-susceptible <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> and coagulase-negative <jats:italic toggle=\"yes\">Staphylococci<\/jats:italic> infections were observed in the group treated with vancomycin powder. An effect of vancomycin powder on methicillin-resistant <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> infection risk was not detected given the low incidence in both the intrawound vancomycin and the standard-of-care groups. There was no emergence of gram-negative rod infections or increased resistance patterns observed. Use of topical vancomycin powder does not seem to produce infections in these patients with greater antibiotic resistance than would have occurred without its use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000002767","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:01:10Z","timestamp":1704992470000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Does Topical Vancomycin Powder Use in Fracture Surgery Change Bacteriology and Antibiotic Susceptibilities? An Analysis of the VANCO Trial"],"prefix":"10.1097","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-3219","authenticated-orcid":false,"given":"Manjari","family":"Joshi","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"O'Toole","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-4515","authenticated-orcid":false,"given":"Anthony R.","family":"Carlini","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-2468","authenticated-orcid":false,"given":"Joshua L.","family":"Gary","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-1842","authenticated-orcid":false,"given":"William T.","family":"Obremskey","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9110-5689","authenticated-orcid":false,"given":"Clinton K.","family":"Murray","sequence":"additional","affiliation":[{"name":"San Antonio Military Medical Center, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-4029","authenticated-orcid":false,"given":"Greg","family":"Gaski","sequence":"additional","affiliation":[{"name":"Inova Fairfax Hospital, Fairfax, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3623-6010","authenticated-orcid":false,"given":"J. Spence","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Rehabilitation, Penn State Health Milton S. Hershey Medical Center, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-9285","authenticated-orcid":false,"given":"Yasmin","family":"Degani","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4349-1527","authenticated-orcid":false,"given":"Tara J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Huang","sequence":"additional","affiliation":[{"name":"University of Michigan School of Dentistry, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-7630","authenticated-orcid":false,"given":"Paul S.","family":"Whiting","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Rehabilitation, University of Wisconsin, Madison, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Louisiana State University Health Sciences Center, New Orleans, LA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-5891","authenticated-orcid":false,"given":"Renan C.","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"METRC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOT.0000000000000158","article-title":"Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fractures","volume":"29","author":"Torbert","year":"2015","journal-title":"J Orthop Trauma"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1097\/BOT.0000000000001305","article-title":"Variations in the organisms causing deep surgical site infections in fracture patients at a level I trauma center (2006-2015)","volume":"32","author":"Montalvo","year":"2018","journal-title":"J Orthop Trauma"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.arth.2022.03.047","article-title":"Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a continued call for a prospective randomized trial","volume":"37","author":"Movassaghi","year":"2022","journal-title":"J Arthroplasty"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EOR-21-0077","article-title":"Intraoperative vancomycin powder to reduce surgical site infections after posterior spine surgery: a systematic review and meta-analysis","volume":"7","author":"Luo","year":"2022","journal-title":"EFORT Open Rev"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7150\/jbji.16649","article-title":"Local intra-wound administration of powdered antibiotics in orthopaedic surgery","volume":"2","author":"Fleischman","year":"2017","journal-title":"J Bone Joint Infect"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.blo.0000144477.43661.59","article-title":"Gentamicin and vancomycin do not impair experimental fracture healing","volume":"427","author":"Haleem","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ajic.2006.05.220","article-title":"Antimicrobial resistance in gram-positive bacteria","volume":"34","author":"Rice","year":"2006","journal-title":"Am J Infect Control"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"e207259","DOI":"10.1001\/jamasurg.2020.7259","article-title":"Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial","volume":"156","author":"O'Toole","year":"2021","journal-title":"JAMA Surg"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s00590-022-03438-1","article-title":"Do superficial infections increase the risk of deep infections in tibial plateau and plafond fractures?","volume":"33","author":"Patterson","year":"2023","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOT.0000000000002458","article-title":"Application of Bayesian methods to help interpret the VANCO trial results","volume":"37","author":"O'Hara","year":"2023","journal-title":"J Orthop Trauma"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/BOT.0000000000001866","article-title":"Systemic absorption and nephrotoxicity associated with topical vancomycin powder for fracture surgery","volume":"35","author":"O'Toole","year":"2021","journal-title":"J Orthop Trauma"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JCM.02098-09","article-title":"Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections","volume":"48","author":"Cremniter","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/323676","article-title":"Glycopeptide resistance among coagulase-negative Staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study","volume":"33","author":"Tacconelli","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/infdis\/173.5.1129","article-title":"Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci","volume":"173","author":"van der Auwera","year":"1996","journal-title":"J Infect Dis"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/AAC.42.5.1303","article-title":"Historical yearly usage of vancomycin","volume":"42","author":"Kirst","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/513766","article-title":"Society for Healthcare epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals","volume":"25","author":"Shlaes","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R22-20250614","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/491714","article-title":"The role of vancomycin in the treatment paradigm","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1067\/mtc.2002.119698","article-title":"Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections","volume":"123","author":"Finkelstein","year":"2002","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:02:37Z","timestamp":1749924157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002767","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}